Dr. Maria T. Grosse-Perdekamp
Claim this profileCarle Cancer Center
About Maria T. Grosse-Perdekamp
Education:
- Earned an MD (Doctor of Medicine), with the institution not specified.
- Completed a Residency in Radiation Oncology at Carle Foundation Hospital in 2019.
- Undertook a Fellowship in Brachytherapy at Carle Foundation Hospital in 2020.
Experience:
- Currently serves as a Radiation Oncologist at Carle Cancer Center.
Area of expertise
Breast Cancer
Maria T. Grosse-Perdekamp has run 14 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Maria T. Grosse-Perdekamp has run 10 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Carle Cancer Center
Carle Physician Group-Effingham
Clinical Trials Maria T. Grosse-Perdekamp is currently running
Triptorelin
for Cancer
This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with an alkylating agents. Alkylating agents are part of standard chemotherapy, but may cause damage to the ovaries. If the ovaries are not working well or completely shut down, then it will be difficult or impossible to get pregnant in the future. Triptorelin works by blocking certain hormones and causing the ovaries to slow down or pause normal activity. The triptorelin used in this study stays active in the body for 24 weeks or about 6 months after a dose is given. After triptorelin is cleared from the body, the ovaries resume normal activities. Adding triptorelin before the start of chemotherapy treatment may reduce the chances of damage to the ovaries.
Recruiting
2 awards
Phase 3
4 criteria
Mobile Health
for Breast Cancer
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting
1 award
N/A
10 criteria
More about Maria T. Grosse-Perdekamp
Clinical Trial Related
3 years of experience running clinical trials · Led 31 trials as a Principal Investigator · 11 Active Clinical Trials
Treatments Maria T. Grosse-Perdekamp has experience with
- Paclitaxel
- Biospecimen Collection
- Atezolizumab
- Carboplatin
- Palbociclib
- Docetaxel
Breakdown of trials Maria T. Grosse-Perdekamp has run
Breast Cancer
Breast cancer
Ovarian Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maria T. Grosse-Perdekamp specialize in?
Maria T. Grosse-Perdekamp focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are HER2 negative.
Is Maria T. Grosse-Perdekamp currently recruiting for clinical trials?
Yes, Maria T. Grosse-Perdekamp is currently recruiting for 11 clinical trials in Urbana Illinois. If you're interested in participating, you should apply.
Are there any treatments that Maria T. Grosse-Perdekamp has studied deeply?
Yes, Maria T. Grosse-Perdekamp has studied treatments such as Paclitaxel, Biospecimen Collection, Atezolizumab.
What is the best way to schedule an appointment with Maria T. Grosse-Perdekamp?
Apply for one of the trials that Maria T. Grosse-Perdekamp is conducting.
What is the office address of Maria T. Grosse-Perdekamp?
The office of Maria T. Grosse-Perdekamp is located at: Carle Cancer Center, Urbana, Illinois 61801 United States. This is the address for their practice at the Carle Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.